Nasdaq is down 0.7%, AMPE 4%. 390,000 shares as of posting. How does that support "No Sellers"? Just seems odd, though most biotechs are indeed down more than the market overall. One might have expected more solid support. Thinking of adding, but position is already a big % of portfolio.
Today really hurt, but it's not company related. It does show the vulnerability of high-beta stocks to the macroeconomic factors. Much as it should be event-driven or via fundamentals, it is not. Hope we all cash out well before the end of the cycle.
Pull up a daily chart and tell me the shorts didn't purposefully bring this stock down below $8.15. There just looking to take it down to a lower support level once it breaks $8.15. It's the stock market and the longs don't seem to want to play today